Top Markets
Coin of the day
Rebus Holdings, Inc. Rebus Holdings, Inc.

Rebus Holdings, Inc.

RBSH
株式のランク #42217
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for... Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$3.21K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Rebus Holdings, Inc. (RBSH)

カテゴリー

Rebus Holdings, Inc.(RBSH)の配当利回りの履歴
Rebus Holdings, Inc.(銘柄コード: RBSH)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Rebus Holdings, Inc.(RBSH)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)